About
Company Strategy
Group Structure
Board of directors
Management
Career
Contacts
Development
Drugs
Medical devices
Medical services
Biotech valuation
Activity
Areas of activities
Research and development (R&D) stages
Ecosystem
Acceleration
Commercialization
Investor
Disclosure of information
News
En
RU
CN
Главная
About the Company
Group Structure
Group Structure
The group includes companies at different development stages: from seed to early growth and maturity.
Group members
Cell technology and tissue engineering
Histograft
Subsidiary・Resident of Skolkovo and Medtech
Developer of the world’s first technology platform of gene-activated materials: medical devices with nucleic acid growth factor precursors for tissue regeneration.
More
Vitacel
Subsidiary
Developer of patented personalized cell technologies for skin therapy and periodontal soft tissue restoration using fibroblasts.
More
Skincel
Subsidiary・Resident of Skolkovo
Developer of an epidermolysis bullosa treatment method based on transplantation of allogeneic human fibroblast-like cells.
More
Ecosystem companies
HSCI Pharma
Subsidiary
Organization of wholesale sales and drugs for the Artgen group company.
More
HSCI Ventures
Subsidiary
Investing at various stages, including acceleration of startup projects.
More
Gene therapy
Nextgen
Subsidiary・Resident of Lomonosov INTC and Medtech
Development and implementation of gene therapy drugs.
More
Genotarget
Associated company・Resident of Skolkovo and Medtech
Developer of gene therapy drugs for the treatment of rare neuromuscular diseases.
More
Swiftgen
Co-development partner for gene therapy drugs
Developer of a technology platform for gene therapy using adeno-associated viruses.
More
ArtGene Therapeutics
ArtGene is an American biotechn company developing its drug candidate ART-101 based on the intellectual property associated with Neovasculgen.
More
Oncology
Castem Biotech
Castem Biotech LLC develops innovative target therapies based on new-generation tyrosine kinase inhibitors for the treatment of aggressive metastatic forms of cancer.
More
Biobanking
Gemabank
Subsidiary
Bank for personal storage of umbilical cord blood stem cells and umbilical cords.
More
Reprobank
Subsidiary
The leader in the Russian market of donation, individual storage and professional transportation of reproductive materials.
More
Vaccines
Betuvax
Subsidiary・Resident of Skolkovo and Medtech
Developer of antigens for the creation of prevention and treatment vaccines based on in silico technologies and rational design.
More
Biotechnology Developments
Associated company・Resident of Skolkovo and Medtech
Developer of the Betusphere platform technology for the creation of subunit recombinant vaccines based on a corpuscular natural adjuvant, betulin, for the prevention of pathogenic infections.
More
Genetic research
Genetico
Subsidiary・Resident of Skolkovo and Medtech
The company deals with medical genetics, development of assays, and creation of gene therapy drugs for the treatment of rare diseases.
More
Antibodies
Proteomarine
Financial investments・Resident of Skolkovo and Medtech
Developer of Russia’s first technology platform of drugs based on shark antibodies for the treatment of a wide range of socially significant diseases.
More
Up
About the Company
About
Company Strategy
Group Structure
Board of Directors
Management
Career
Contacts
Development Portfolio
Drugs
Medical Devices
Medical Services
Activity
Areas of activities
Research and development (R&D) stages
Ecosystem
Acceleration
Commercialization
Biotech Valuation
Investors
Disclosure of information